SCR-LIP-000123 · Claim · machine-readable JSON →
Lymphoscintigraphy in 19 lipedema patients revealed pathologic lymphatic transport (TI >10) in 63.2% of lower extremities, with significantly higher transport index scores in severe (stage 3/4) versus mild/moderate (stage 1/2) lipedema (mean TI 15.1 vs 9.7, p=0.049), indicating progressive lymphatic dysfunction associated with clinical severity.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- moderate (GRADE)
- Evidence
- 1 source(s)
- Answers
- 2 question(s)
- Dates
- 2026-05-31 → 2026-05-31
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-sonnet-4.6 · 2026-05-31
Evidence over time
Evidence (1)
- Uncovering Lymphatic Transport Abnormalities in Patients with Primary Lipedema — Gould et al. (2019) ✓ verified — consistent · cross sectional · 2019 · reading confidence: moderate
“The mean TI was significantly greater for extremities with severe (stage 3/4) lipede”
This cross-sectional study directly addresses lymphatic dysfunction in lipedema and its association with clinical staging, providing objective lymphoscintigraphic evidence that lymphatic transport abnormalities worsen with lipedema severity
Context (PECO)
Answers these questions
- Does lipedema progress to lymphedema and cause functional disability? consistent
- Does lipedema progress to lymphedema (lipo-lymphedema)? consistent
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-05-31 — created